Pharyngitis Epidemiology Forecast 2025-2034

It is estimated that in approximately 50% to 80% of pharyngitis (sore throat) cases, the symptoms are viral in origin and comprise a variety of viral pathogens, predominantly coronavirus, rhinovirus, influenza, adenovirus, and parainfluenza. In temperate climates, pharyngitis is prevalent during winter and early spring.

Pharyngitis Epidemiology Forecast Report Coverage

The “Pharyngitis Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of pharyngitis. It projects the future incidence and prevalence rates of pharyngitis across various populations. The study covers age, gender, and type as major determinants of the pharyngitis-affected population. The report highlights patterns in the prevalence of pharyngitis over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of pharyngitis in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Pharyngitis: Disease Overview

Pharyngitis, commonly referred to as a sore throat, is an inflammation of the pharynx. It is usually caused by viral or bacterial infections. Environmental factors such as allergens, smoke, or pollutants can also contribute to the development of pharyngitis. Common symptoms include sore throat, difficulty swallowing, fever, swollen lymph nodes, and redness in the throat. Bacterial pharyngitis, typically caused by Group A Streptococcus (GAS), can lead to more serious complications if not treated properly.

Pharyngitis: Treatment Overview

In cases of viral pharyngitis, treatment focuses on relieving symptoms, including rest, staying hydrated, and using over-the-counter pain relievers such as acetaminophen or ibuprofen to reduce fever and ease throat pain. On the other hand, antibiotics such as penicillin or amoxicillin are used for the treatment of bacterial pharyngitis. If the patient is allergic to penicillin, alternatives like azithromycin are usually prescribed to treat the infection and prevent complications like rheumatic fever.

Epidemiology

The pharyngitis epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for pharyngitis by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for pharyngitis and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• It is reported that approximately 50% to 80% of pharyngitis symptoms are viral in origin, primarily caused by influenza, rhinovirus, and adenovirus, among others.
• Group A beta-hemolytic streptococci is the most common bacterial infection, accounting for 5% to 36% of acute pharyngitis cases.
• Approximately 20% to 30% of sore throats in children and 5% to 15% of sore throats in adults are caused by Group A Streptococcus.
• Various studies indicate that the combined cumulative incidence rate of sore throat is 31.9 cases per 100 children.

Country-wise Pharyngitis Epidemiology

The pharyngitis epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of pharyngitis varies between countries, owing to differences in pathogen prevalence, healthcare access, diagnostic practices, climate, and hygiene practices. Additionally, factors like crowded living conditions and seasonal variations can impact the frequency and type of pharyngitis reported in different regions. In the United States, about 12 million annual ambulatory care visits are attributed to acute pharyngitis.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of pharyngitis based on several factors.
• Pharyngitis Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of pharyngitis are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of pharyngitis epidemiology in the 8 major markets?
• What will be the total number of patients with pharyngitis across the 8 major markets during the forecast period?
• What was the country-wise prevalence of pharyngitis in the 8 major markets in the historical period?
• Which country will have the highest number of pharyngitis patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of pharyngitis during the forecast period of 2025-2034?
• What are the currently available treatments for pharyngitis?
• What are the disease risks, signs, symptoms, and unmet needs of pharyngitis?

This product will be delivered within 3-5 business days.